IMS Health to Participate in Credit Suisse Conference and Barclays Conference in December

IMS Health (NYSE:IMS) announced today that the company will participate at the following investor conferences during the month of December:

  • Sati Sian, senior vice president, Global Technology & Operations, will participate in a fireside chat at the Credit Suisse 18th Annual Technology Conference in Scottsdale, AZ on Thursday, December 4, 2014 at 10:00 a.m. MST/12:00 p.m. EST.
  • Ron Bruehlman, senior vice president and chief financial officer, will participate in a fireside chat on Tuesday, December 9, 2014, at the Barclays Global Technology Conference in San Francisco, CA at 11:00 a.m. PST/2 p.m. EST.

Live audio webcasts of these sessions will be available on the IMS Health Investor Relations website at http://ir.imshealth.com. Replays of the webcasts also will be available later the same day.

About IMS Health

IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. By applying sophisticated analytics and proprietary application suites hosted on the IMS One intelligent cloud, the company connects more than 10 petabytes of complex healthcare data on diseases, treatments, costs and outcomes to help its clients run their operations more efficiently. Drawing on information from 100,000 suppliers, and on insights from more than 45 billion healthcare transactions processed annually, IMS Health’s approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at www.imshealth.com.

As a global leader in protecting individual patient privacy, IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. These insights help biotech and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders to identify unmet treatment needs and understand the effectiveness and value of pharmaceutical products in improving overall health outcomes.

IMSFIN

Contacts:

IMS Health
Tom Kinsley, 203-448-4691
Investor Relations
tkinsley@imshealth.com
or
Tor Constantino, 484-567-6732
Media Relations
tconstantino@us.imshealth.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.